Advances in Osteoporosis Drug Development
Osteoporosis remains a pervasive skeletal disorder characterized by decreased bone mass and microarchitectural deterioration, leading to enhanced fracture risk. This article examines recent breakthroughs in drug development targeting bone remodeling,…